{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:53:55Z","timestamp":1788836035727,"version":"build-2803163510"},"reference-count":119,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Nuroendocrine neoplasms (NENs) are a group of rare neoplasms originating from dispersed neuroendocrine cells, mainly of the digestive and respiratory tract, showing characteristic histology and immunoprofile contributing to classification of NENs. Some NENs have the ability to produce biogenic amines and peptide hormones, which may be associated with clinical syndromes like, e.g., the carcinoid syndrome caused by unmetabolized overproduced serotonin, hypoglycemic syndrome in case of insulinoma, or Zollinger-Ellison syndrome accompanying gastrinoma. Diagnostics for these include ultrasound with endoscopic ultrasound (EUS), computed tomography (CT), magnetic resonance imaging (MRI), and positron-emission tomography\/computed tomography (PET\/CT). Different nuclear medicine procedures can also be used, like somatostatin analogues scintigraphy (SRS) and 68Ga-Dota-Peptide PET\/CT, as well as biochemical methods to determine the level of general neuroendocrine markers, such as chromogranin A (CgA), 5-hydroxyindolacetic acid (5-HIAA), synaptopfysin and cell type-specific peptide hormones, and neurotransmitters like gastrin, insulin, serotonin, and histamine. NENs influence the whole organism by modulating metabolism. The treatment options for neuroendocrine neoplasms include surgery, somatostatin analogue therapy, radionuclide therapy, chemotherapy, molecular targeted therapies, alpha-interferon therapy, and inhibitors of serotonin production. In the case of hypersensitivity to biogenic amines, a diet that limits the main sources of amines should be used. The symptoms are usually connected with histamine, tyramine and putrescine. Exogenic sources of histamine are products that take a long time to mature and ferment. Patients with a genetic insufficiency of the diamine oxidase enzyme (DAO), and those that take medicine belonging to the group of monoamine oxidases (MAO), are particularly susceptible to the negative effects of amines. Diet plays an important role in the initiation, promotion, and progression of cancers. As a result of the illness, the consumption of some nutrients can be reduced, leading to nutritional deficiencies and resulting in malnutrition. Changes in metabolism may lead to cachexia in some patients suffering from NENs. The aim of this narrative review was to advance the knowledge in this area, and to determine possibilities related to dietary support. The authors also paid attention to role of biogenic amines in the treatment of patients with NENs. We can use this information to better understand nutritional issues faced by patients with gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs), and to help inform the development of screening tools and clinical practice guidelines.<\/jats:p>","DOI":"10.3390\/nu12051437","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T10:53:59Z","timestamp":1589540039000},"page":"1437","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0393-6288","authenticated-orcid":false,"given":"Jakub","family":"Pob\u0142ocki","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Metabolic Diseases and Internal Diseases, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1str, 70-252 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jasi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Human Nutrition and Metabolomic, Pomeranian Medical University in Szczecin, Broniewskiego 24 str, 71-460 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anhelli","family":"Syrenicz","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolic Diseases and Internal Diseases, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1str, 70-252 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Andrysiak-Mamos","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolic Diseases and Internal Diseases, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1str, 70-252 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9808-0624","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Szczuko","sequence":"additional","affiliation":[{"name":"Department of Human Nutrition and Metabolomic, Pomeranian Medical University in Szczecin, Broniewskiego 24 str, 71-460 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00423-011-0739-1","article-title":"The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors","volume":"396","author":"Schimmack","year":"2011","journal-title":"Langenbecks Arch. Chir."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neo.2017.09.002","article-title":"Nothing but NET: A Review of Neuroendocrine Tumors and Carcinomas","volume":"19","author":"Oronsky","year":"2017","journal-title":"Neoplasia"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000459404","article-title":"Early Gastroenteropancreatic Neuroendocrine Tumors: Endoscopic Therapy and Surveillance","volume":"33","author":"Cadiot","year":"2017","journal-title":"Visc. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrendo.2011.120","article-title":"Neuroendocrine neoplasms of the gut and pancreas: New insights","volume":"8","author":"Rindi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"v220","DOI":"10.1093\/annonc\/mdq191","article-title":"On behalf of the ESMO Guidelines Working Group Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Hellman","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000481390","article-title":"Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications","volume":"33","year":"2017","journal-title":"Visc. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000080731","article-title":"Epidemiology of Neuroendocrine Tumours","volume":"80","author":"Taal","year":"2004","journal-title":"Neuroendocrinology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2013.07.015","article-title":"Gastroenteropancreatic endocrine tumors","volume":"386","author":"Meeker","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_9","first-page":"420795","article-title":"ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours","volume":"2013","author":"Srirajaskanthan","year":"2013","journal-title":"ISRN Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/flgastro-2014-100483","article-title":"A guide to midgut neuroendocrine tumours (NETs) and carcinoid syndrome","volume":"6","author":"Cheung","year":"2014","journal-title":"Front. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000333035","article-title":"The Novel WHO 2010 Classification for Gastrointestinal Neuroendocrine Tumours Correlates Well with the Metastatic Potential of Rectal Neuroendocrine Tumours","volume":"95","author":"Jernman","year":"2012","journal-title":"Neuroendocrinology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1572-0241.2007.01185.x","article-title":"A Three-Decade Analysis of 3,911 Small Intestinal Neuroendocrine Tumors: The Rapid Pace of No Progress","volume":"102","author":"Modlin","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clin. Nutr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1080\/10408398.2017.1390729","article-title":"On behalf of NIKE Group The management of neuroendocrine tumours: A nutritional viewpoint","volume":"59","author":"Gallo","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cca.2018.03.030","article-title":"Comparison of serum serotonin and serum 5-HIAA LC-MS\/MS assays in the diagnosis of serotonin producing neuroendocrine neoplasms: A pilot study","volume":"482","author":"Tohmola","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00120-017-0523-0","article-title":"Neuroendokrines Prostatakarzinom","volume":"56","author":"Tritschler","year":"2017","journal-title":"Der Urol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Koenig, A., Krug, S., Mueller, D., Barth, P.J., Koenig, U., Scharf, M., Ellenrieder, V., Michl, P., Moll, R., and Homayunfar, K. (2017). Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0188876"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.3892\/ol.2017.5735","article-title":"Expression of IMP3 as a marker for predicting poor outcome in gastroenteropancreatic neuroendocrine neoplasms","volume":"13","author":"Er","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11154-017-9438-8","article-title":"Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?","volume":"18","author":"Fottner","year":"2017","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s12630-012-9879-1","article-title":"Mega-dose intravenous octreotide for the treatment of carcinoid crisis: A systematic review","volume":"60","author":"Seymour","year":"2013","journal-title":"Can. J. Anesth."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000471879","article-title":"ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging","volume":"105","author":"Sundin","year":"2017","journal-title":"Neuroendocrinology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11154-018-9443-6","article-title":"Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important","volume":"19","author":"Jin","year":"2018","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000443172","article-title":"Consensus Guidelines for High Grade Gastro-Entero-Pancreatic (GEP) Neuroendocrine Tumours and Neuroendocrine Carcinomas (NEC)","volume":"103","author":"Sorbye","year":"2016","journal-title":"Neuroendocrinology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2217\/ije-2016-0006","article-title":"The ENETS\/WHO grading system for neuroendocrine neoplasms of the gastroenteropancreatic system: A review of the current state, limitations and proposals for modifications","volume":"3","author":"Cavalcanti","year":"2016","journal-title":"Int. J. Endocr. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000443170","article-title":"ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum","volume":"103","author":"Niederle","year":"2016","journal-title":"Neuroendocrinology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ecl.2018.04.008","article-title":"The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia","volume":"47","author":"Inzani","year":"2018","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MD.0b013e3182954af1","article-title":"Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1","volume":"92","author":"Ito","year":"2013","journal-title":"Medicine"},{"key":"ref_29","first-page":"79","article-title":"Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours)","volume":"68","author":"Strzelczyk","year":"2017","journal-title":"Endokrynol Pol."},{"key":"ref_30","first-page":"72","article-title":"Carcinoid tumor of the gallbladder: Laparoscopic resection and review of the literature. Videosurgery and other miniinvasive techniques","volume":"4","author":"Modrzejewski","year":"2009","journal-title":"Surgery"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One Hundred Years After \u201cCarcinoid\u201d: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_32","unstructured":"Pandit, S., and Bhusal, K. (2020, January 01). Carcinoid Syndrome, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448096\/."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.amjcard.2010.12.025","article-title":"Risk factors for the development and progression of carcinoid heart disease","volume":"107","author":"Bhattacharya","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/postgradmedj-2017-134847","article-title":"Gastrointestinal manifestations of neuroendocrine tumours: Their investigation and management","volume":"93","author":"Sagar","year":"2017","journal-title":"Postgrad. Med. J."},{"key":"ref_35","first-page":"906","article-title":"Neuroendocrine tumors\u2014Insulinoma in clinical practice","volume":"12","author":"Gierach","year":"2013","journal-title":"Post\u0119py Nauk Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1634\/theoncologist.2013-0369","article-title":"Zollinger-Ellison Syndrome: Classical Considerations and Current Controversies","volume":"19","author":"Epelboym","year":"2013","journal-title":"Oncologist"},{"key":"ref_37","unstructured":"Cingam, S.R., and Karanchi, H. (2020, January 01). Gastrinoma, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441842\/."},{"key":"ref_38","unstructured":"Sandhu, S., and Jialal, I. (2020, January 01). VIPoma. Copyright\u00a9 2018, StatPearls Publishing LLC, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507698\/."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/jdv.13752","article-title":"Glucagonoma syndrome: A review and update on treatment","volume":"30","author":"John","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_40","unstructured":"Vinink, A., Pacak, K., Feliberti, E., and Perry, R.R. (2020, January 01). Glucagonoma Syndrome, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279041\/."},{"key":"ref_41","unstructured":"Vinik, A., Pacak, K., Feliberti, E., and Perry, R.R. (2020, January 01). Somatostatinoma, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279034\/."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1677\/ERC-07-0157","article-title":"Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: Incidence, types, biological behavior, association with inherited syndromes, and functional activity","volume":"15","author":"Garbrecht","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1634\/theoncologist.2015-0476","article-title":"Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement","volume":"21","author":"Coriat","year":"2016","journal-title":"Oncologist"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00268-016-3432-2","article-title":"Surgical Treatment of NEN of Small Bowel: A Retrospective Analysis","volume":"40","author":"Watzka","year":"2016","journal-title":"World J. Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/j.gastro.2017.03.008","article-title":"Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice","volume":"153","author":"Jiang","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1530\/ERC-10-0271","article-title":"Therapeutic management of patients with gastroenteropancreatic neuroendocrine tumours","volume":"18","author":"Khan","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1756-9966-29-19","article-title":"Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives","volume":"29","author":"Appetecchia","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group","volume":"27","author":"Rinke","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors","volume":"371","author":"Caplin","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1053\/j.seminoncol.2006.04.005","article-title":"New Paradigms in Anticancer Therapy: Targeting Multiple Signaling Pathways With Kinase Inhibitors","volume":"33","author":"Faivre","year":"2006","journal-title":"Semin. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11864-017-0514-9","article-title":"Update in the Therapy of Advanced Neuroendocrine Tumors","volume":"18","author":"Uri","year":"2017","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_53","first-page":"480","article-title":"Neuroendocrine neoplasms of the small intestine and appendicitis - principles of conduct (recommended by the Polish Neuroendocrine Tumor Network)","volume":"64","author":"Bednarczuk","year":"2013","journal-title":"Endokrynol. Pol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0140-6736(15)00817-X","article-title":"Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): A randomised, placebo-controlled, phase 3 study","volume":"387","author":"Yao","year":"2015","journal-title":"Lancet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1530\/ERC-17-0531","article-title":"Emerging multitarget tyrosine kinase inhibitors in the treatment of neuroendocrine neoplasms","volume":"25","author":"Grillo","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1530\/ERC-17-0455","article-title":"Telotristat ethyl in carcinoid syndrome: Safety and efficacy in the TELECAST phase 3 trial","volume":"25","author":"Pavel","year":"2018","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1200\/JCO.2016.68.0702","article-title":"Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study","volume":"34","author":"Yao","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_59","first-page":"498","article-title":"A retrospective study of capecitabine\/temozolomide (CAPTEM) regimen in the treatment of metastatic pancreatic neuroendocrine tumors (pNETs) afer failing previous therapy","volume":"14","author":"Saif","year":"2013","journal-title":"J. Pancreas"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"9032753","DOI":"10.1155\/2019\/9032753","article-title":"CAPTEM in Metastatic Well-Differentiated Intermediate to High Grade Neuroendocrine Tumors: A Single Centre Experience","volume":"2019","author":"Sahu","year":"2019","journal-title":"J. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443167","article-title":"ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site","volume":"103","author":"Pavel","year":"2016","journal-title":"Neuroendocrinology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/jamaoncol.2018.6720","article-title":"Therapeutic Options for Neuroendocrine Tumors","volume":"5","author":"Kaderli","year":"2019","journal-title":"JAMA Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Liu, T., Liao, J., Dang, J., and Li, G. (2019). Treatments for patients with advanced neuroendocrine tumors: A network meta-analysis. Ther. Adv. Med. Oncol., 11.","DOI":"10.1177\/1758835919853673"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.critrevonc.2015.11.003","article-title":"Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy\u2014A literature review","volume":"98","author":"Berardi","year":"2016","journal-title":"Crit. Rev. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1158\/1055-9965.EPI-16-0439","article-title":"The Obesity Paradox in Cancer-Moving Beyond BMI","volume":"26","author":"Shachar","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0092-8674(02)00818-8","article-title":"p53: Good cop\/bad cop","volume":"110","author":"Sharpless","year":"2002","journal-title":"Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jama.297.9.986","article-title":"Aging, Adiposity, and Calorie Restriction","volume":"297","author":"Fontana","year":"2007","journal-title":"JAMA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrc1189","article-title":"Cancer chemoprevention with dietary phytochemicals","volume":"3","author":"Surh","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ecl.2010.08.003","article-title":"Nutrition and Gastroenteropancreatic Neuroendocrine Tumors","volume":"39","author":"Go","year":"2010","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Barrea, L., Altieri, B., Muscogiuri, G., Laudisio, D., Annunziata, G., Colao, A., Faggiano, A., and Savastano, S. (2018). Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness. Nutrients, 10.","DOI":"10.3390\/nu10121854"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"g4490","DOI":"10.1136\/bmj.g4490","article-title":"Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: Systematic review and dose-response meta-analysis of prospective cohort studies","volume":"349","author":"Wang","year":"2014","journal-title":"BMJ"},{"key":"ref_72","first-page":"1","article-title":"Obesity as a Major Risk Factor for Cancer","volume":"2013","author":"Silvestris","year":"2013","journal-title":"J. Obes."},{"key":"ref_73","first-page":"21","article-title":"Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives","volume":"79","author":"Hofland","year":"2018","journal-title":"Drugs"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11154-018-9466-z","article-title":"Nutrition and neuroendocrine tumors: An update of the literature","volume":"19","author":"Altieri","year":"2018","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tips.2009.11.004","article-title":"Calorie restriction and cancer prevention: Metabolic and molecular mechanisms","volume":"31","author":"Longo","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1017\/S0007114515000148","article-title":"Fruit and vegetables and cancer risk: A review of southern European studies","volume":"113","author":"Turati","year":"2015","journal-title":"Br. J. Nutr."},{"key":"ref_77","unstructured":"Promotion (2020, January 01). USDoHaHSOoDPaH, Available online: https:\/\/health.gov\/dietaryguidelines\/?_ga=2.93506781.1509651194.1526503567-2137365160.1526503567."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1200\/JCO.2007.14.6217","article-title":"Cancer Survivors\u2019 Adherence to Lifestyle Behavior Recommendations and Associations With Health-Related Quality of Life: Results From the American Cancer Society\u2019s SCS-II","volume":"26","author":"Blanchard","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_79","unstructured":"Dietary Guidelines Advisory Committee, US Department of Health and Human Services, and US Department of Agriculture (2005). Dietary Guidelines for Americans 2005."},{"key":"ref_80","first-page":"1660","article-title":"The importance of lactic acid bacteria for the prevention of bacterial growth and their biogenic amines formation: A review","volume":"58","author":"Hamed","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/19393210.2013.831488","article-title":"Biogenic amines in commercially produced Yulu, a Chinese fermented fish sauce","volume":"7","author":"Jiang","year":"2013","journal-title":"Food Addit. Contam. Part B"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2174\/1389203717666160627073048","article-title":"Roles of Biogenic Amines in Intestinal Signaling","volume":"18","author":"Fan","year":"2017","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.foodres.2018.05.020","article-title":"Biogenic amines and other polar compounds in long aged oxidized Vernaccia di Oristano white wines","volume":"111","author":"Tuberoso","year":"2018","journal-title":"Food Res. Int."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.aller.2016.04.015","article-title":"Histamine intolerance and dietary management: A complete review","volume":"44","author":"Martin","year":"2016","journal-title":"Allergol. Immunopathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5414\/ALX01420E","article-title":"Allergic and intolerance reactions to wine","volume":"2","year":"2018","journal-title":"Allergol. Sel."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/17425255.2017.1273901","article-title":"Use of monoamine oxidase inhibitors in chronic neurodegeneration","volume":"13","author":"Riederer","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_87","first-page":"579","article-title":"Microbial Patterns in Patients with Histamine Intolerance","volume":"69","author":"Schink","year":"2018","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.fct.2016.11.011","article-title":"Tyramine and histamine risk assessment related to consumption of dry fermented sausages by the Spanish population","volume":"99","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"ref_89","first-page":"395","article-title":"Significance of Biogenic Amines in Foods and Their Reduction Methods","volume":"3","author":"Ercan","year":"2013","journal-title":"J. Food Sci. Eng."},{"key":"ref_90","first-page":"378","article-title":"Biogenic amines in smear ripened cheeses","volume":"13","author":"Franke","year":"2019","journal-title":"Potravin. Slovak J. Food Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/MPA.0000000000001384","article-title":"Management of Diarrhea in Patients With Carcinoid Syndrome","volume":"48","author":"Naraev","year":"2019","journal-title":"Pancreas"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3748\/wjg.v25.i10.1171","article-title":"Nutritional and vitamin status in patients with neuroendocrine neoplasms","volume":"25","author":"Clement","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e11228","DOI":"10.2196\/11228","article-title":"Investigating Nutrition-Related Complications and Quality of Life in Patients With Gastroenteropancreatic Neuroendocrine Tumors: Protocol for a Mixed-Methods Prospective Study","volume":"7","author":"Laing","year":"2018","journal-title":"JMIR Res. Protoc."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/ajcn\/84.5.1163","article-title":"Dietary patterns in patients with advanced cancer: Implications for anorexia-cachexia therapy","volume":"84","author":"Hutton","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1188\/12.CJON.413-417","article-title":"Treatment-Related Diarrhea in Patients with Cancer","volume":"16","author":"Shaw","year":"2012","journal-title":"Clin. J. Oncol. Nurs."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S1470-2045(06)70976-7","article-title":"Diet, exercise, and complementary therapies after primary treatment for cancer","volume":"7","author":"Jones","year":"2006","journal-title":"Lancet Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Paris, S., Garc\u00eda, M., Trufero, M., Sorrosal, L., Gracia, C., Alaminos, L., Sanz-Par\u00eds, A., Martinez-Garc\u00eda, M., Trufero, J.M., and Lambea, J. (2019). Oligomeric Enteral Nutrition in Undernutrition, due to Oncology Treatment-Related Diarrhea. Systematic Review and Proposal of An Algorithm of Action. Nutrients, 11.","DOI":"10.3390\/nu11081888"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jand.2016.05.010","article-title":"Oncology Evidence-Based Nutrition Practice Guideline for Adults","volume":"117","author":"Thompson","year":"2017","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/apt.12316","article-title":"Systematic review: The efficacy of nutritional interventions to counteract acute gastrointestinal toxicity during therapeutic pelvic radiotherapy","volume":"37","author":"Wedlake","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_100","first-page":"162","article-title":"Link between diet and chemotherapy related gastrointestinal side effects","volume":"21","author":"Mardas","year":"2017","journal-title":"Contemp. Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bpg.2016.06.001","article-title":"Management of radiation and chemotherapy related acute toxicity in gastrointestinal cancer","volume":"30","author":"Grabenbauer","year":"2016","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"L23","DOI":"10.1530\/ERC-17-0549","article-title":"Towards optimal personalized diet and vitamin supplementation in NET patients","volume":"25","author":"Stelwagen","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12937-015-0106-0","article-title":"Low-FODMAP formula improves diarrhea and nutritional status in hospitalized patients receiving enteral nutrition: A randomized, multicenter, double-blind clinical trial","volume":"14","author":"Yoon","year":"2015","journal-title":"Nutr. J."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s00520-006-0040-y","article-title":"Cancer chemotherapy-induced diarrhoea and constipation: Mechanisms of damage and prevention strategies","volume":"14","author":"Gibson","year":"2006","journal-title":"Support. Care Cancer"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1136\/gutjnl-2016-313271","article-title":"Prebiotic inulin-type fructans induce specific changes in the human gut microbiota","volume":"66","author":"Vandeputte","year":"2017","journal-title":"Gut"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3920\/BM2017.0049","article-title":"Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: Improvement in symptoms and bowel habit in functional constipation","volume":"9","author":"Riezzo","year":"2018","journal-title":"Benef. Microbes"},{"key":"ref_107","first-page":"223","article-title":"Microbiome of the digestive tract and its dysbiosis as an important factor affecting the health condition of the human body","volume":"66","author":"Januszkiewicz","year":"2014","journal-title":"Med. Do\u015bw. Mikrobiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000440621","article-title":"Niacin (Vitamin B-3) supplementation in patients with serotonin-producing neuroendocrine tumor","volume":"103","author":"Bouma","year":"2016","journal-title":"Neuroendocrinology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1111\/j.1572-0241.2005.00268.x","article-title":"Biochemical Assessment of Niacin Deficiency Among Carcinoid Cancer Patients","volume":"100","author":"Shah","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"ref_110","first-page":"126","article-title":"Pancreatic Enzyme Replacement Therapy: A Concise Review","volume":"20","author":"Brennan","year":"2019","journal-title":"J. Pancreas"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e010765","DOI":"10.1136\/bmjopen-2015-010765","article-title":"Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: A cross-sectional study","volume":"6","author":"Qureshi","year":"2016","journal-title":"BMJ Open"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.clnu.2006.01.020","article-title":"ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology","volume":"25","author":"Arends","year":"2006","journal-title":"Clin. Nutr."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/cncr.11671","article-title":"The burdens of cancer therapy","volume":"98","author":"Elting","year":"2003","journal-title":"Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/00365521.2018.1430848","article-title":"Nutritional status and nutritional risk in patients with neuroendocrine tumors","volume":"53","author":"Borre","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1080\/01635581.2018.1470650","article-title":"Supplementation of Vitamin D Deficiency in Patients with Neuroendocrine Tumors Using Over-the-Counter Vitamin D3 Preparations","volume":"70","author":"Robbins","year":"2018","journal-title":"Nutr. Cancer"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.clnesp.2018.02.006","article-title":"Should omega-3 fatty acids be used for adjuvant treatment of cancer cachexia?","volume":"25","author":"Lavriv","year":"2018","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"dmm033332","DOI":"10.1242\/dmm.033332","article-title":"Arginine and the metabolic regulation of nitric oxide synthesis in cancer","volume":"11","author":"Keshet","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000442983","article-title":"Malnutrition Predicts Clinical Outcome in Patients with Neuroendocrine Neoplasia","volume":"104","author":"Maasberg","year":"2015","journal-title":"Neuroendocrinology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/17474124.2018.1489232","article-title":"Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: Results of a prospective observational study","volume":"12","author":"Lamarca","year":"2018","journal-title":"Expert Rev. Gastroenterol. Hepatol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/5\/1437\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:29:18Z","timestamp":1760174958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/5\/1437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":119,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["nu12051437"],"URL":"https:\/\/doi.org\/10.3390\/nu12051437","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,15]]}}}